EUVIMEDOpdag EUVIMED
Crossref

MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy

Feifei Shen, Xiaohuan Li iD, Haili Qi, Wei Yu, Yuan Liu, Zhanping Guo

Molecular Carcinogenesis · 2026-10-06

DOI: 10.1002/mc.70189 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2026-10-06. Written by Feifei Shen and 5 co-authors. Institution: Department of Endoscopic Diagnosis and Treatment, Xinxiang Central Hospital, Xinxiang, China. 35 references. Funded by: Clinical efficacy and prognosis of endoscopic mucosal dissection in the treatment of early gastric cancer and precancerous lesions.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Melanoma‐associated antigen A6 (MAGEA6) is aberrantly expressed in several cancers and exhibits oncogenic activity. This study aimed to investigate the function and underlying mechanisms of MAGEA6 in gastric cancer (GC). The TCGA dataset was utilized in this study to evaluate MAGEA6 expression in GC. Subsequently, the Transwell assay, EDU labeling, and the Cell Counting Kit‐8 were employed to assess the effects of MAGEA6 on the migration and proliferation of GC cells. Mitochondrial autophagy and activity examined using mito‐Keima staining, transmission electron microscopy, and the JC‐1 assay.We found that MAGEA6 was highly expressed in GC patient tissues and cell lines. Overexpression of MAGEA6 enhanced the migratory and proliferative capabilities of GC cells. Additionally, MAGEA6 overexpression promoted mitophagy and prevented mitochondrial collapse. Mechanistically, MAGEA6 activated the PINK1/PRKN pathway by upregulating the protein expression of S100A9, a mechanism closely associated with the pro‐cancer phenotype of MAGEA6.The MAGEA6/S100A9/PINK1/PRKN mitophagy pathway is a potential mechanism that promotes GC progression. It may serve as a promising target for GC therapy.

Subjects

Author keywords

MAGEA6gastric cancermitophagy

Authors and institutions

  • Department of Endoscopic Diagnosis and Treatment, Xinxiang Central Hospital, Xinxiang, China.

ORCID profiles: Xiaohuan Li

Funding

  • Clinical efficacy and prognosis of endoscopic mucosal dissection in the treatment of early gastric cancer and precancerous lesions

Cite

APA

Shen, F., Li, X., Qi, H., Yu, W., Liu, Y., & Guo, Z. (2026). MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70189

Vancouver

Shen F, Li X, Qi H, Yu W, Liu Y, Guo Z. MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70189

BibTeX
@article{Shen2026,
  author = {Shen, Feifei and Li, Xiaohuan and Qi, Haili and Yu, Wei and Liu, Yuan and Guo, Zhanping},
  title = {MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70189}
}
Start for free →